News
CLGN
8.00
-0.12%
-0.01
Collplant Holdings (CLGN) Has a New Rating from Alliance Global Partners
TipRanks · 02/17 16:25
Alliance Global Partners Initiates Coverage On CollPlant Biotechnologies with Buy Rating, Announces Price Target of $22.75
Benzinga · 02/17 13:35
CollPlant: Expanding End-Market Opportunities
Seeking Alpha · 02/12 11:31
Top 5 Health Care Stocks That May Dip
Benzinga · 01/27 11:33
CollPlant Announced Pre-Clinical Results in 3D Bioprinted Regenerative Breast Implants Porcine Study and Full Achievement of Objectives
Benzinga · 01/04 12:19
CollPlant Enriches Portfolio Of rhCollagen-Based Bioinks With Launch Of Collink.3DTM 50L In Powder Form
Benzinga · 01/03 12:06
12 Health Care Stocks Moving In Monday's Pre-Market Session
Benzinga · 12/05/2022 13:08
BRIEF-Collplant Biotechnologies Provides Q3 2022 Financial Results
Reuters · 12/01/2022 12:17
CollPlant Biotechnologies Q3 EPS $(0.34) Misses $(0.31) Estimate, Sales $109.00K Down From $140.00K YoY
Benzinga · 12/01/2022 12:05
CollPlant Biotechnologies Provides Business Updates and Third Quarter 2022 Financial Results
CollPlant Biotechnologies (Nasdaq: CLGN), a regenerative and aesthetic medicine company developing innovative human collagen-based technologies and products for tissue regeneration and organ manufacturing, today announced financial results for the third qu...
PR Newswire · 12/01/2022 12:00
-- Earnings Flash (CLGN) COLLPLANT Posts Q3 Loss $-0.34
-- Earnings Flash (CLGN) COLLPLANT Posts Q3 Loss $-0.34
MT Newswires · 12/01/2022 07:15
-- Earnings Flash (CLGN) COLLPLANT Posts Q3 Revenue $109,000
-- Earnings Flash (CLGN) COLLPLANT Posts Q3 Revenue $109,000
MT Newswires · 12/01/2022 07:13
BRIEF-Collplant, Tel Aviv University And Sheba Medical Center To Co-Develop 3D Bioprinted Human Intestine Model For Drug Discovery
Reuters · 11/15/2022 12:38
CollPlant, Tel Aviv University And Sheba Medical Center Join Forces To Co-Develop rhCollagen-Based 3D Bioprinted Human Intestine Model For Drug Discovery And Personalized Treatment Of Ulcerative Colitis
Benzinga · 11/15/2022 12:14
CollPlant, Tel Aviv University, Sheba Medical Center to Co-Develop Tissue Model for Drug Discovery to Treat Ulcerative Colitis
CollPlant, Tel Aviv University, Sheba Medical Center to Co-Develop Tissue Model for Drug Discovery to Treat Ulcerative Colitis
MT Newswires · 11/15/2022 09:22
CollPlant Expands rhCollagen-Based Bioink Platform with Launch of Collink.3D™ 90
CollPlant (Nasdaq: CLGN), a regenerative and aesthetics medicine company developing innovative human collagen-based technologies and products for tissue regeneration and organ manufacturing, today announced the Company is launching Collink.3D™ 90, a recomb...
PR Newswire · 11/07/2022 12:00
CollPlant to Present at Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum on November 17
CollPlant Biotechnologies (NASDAQ: CLGN), a regenerative and aesthetics medicine company developing innovative human-collagen based technologies and products for tissue regeneration and organ manufacturing, today announced that Eran Rotem, Collplant's Depu...
PR Newswire · 11/03/2022 11:00
CollPlant to present at the Dawson James Small Cap Growth Conference on October 12
CollPlant Biotechnologies (Nasdaq: CLGN), a regenerative and aesthetics medicine company developing innovative technologies and products for tissue regeneration and organ manufacturing, today announced that the Company's Deputy CEO & Chief Financial Office...
PR Newswire · 10/03/2022 11:00
CollPlant to Present at the International Conference on Biofabrication 2022 in Tuscany, Italy
CollPlant (NASDAQ: CLGN), a regenerative and aesthetics medicine company developing innovative human collagen-based technologies and products for tissue regeneration and organ manufacturing, today announced the Company will make a presentation on "Recombin...
PR Newswire · 09/19/2022 11:00
CollPlant Biotechnologies to Participate in September Investor Conferences
CollPlant Biotechnologies (Nasdaq: CLGN), a regenerative and aesthetic medicine company developing innovative human collagen-based technologies and products for tissue regeneration and organ manufacturing, today announced that Deputy CEO and CFO Eran Rotem...
PR Newswire · 09/06/2022 11:00
More
Webull provides a variety of real-time CLGN stock news. You can receive the latest news about Collplant Biotechnologies Ltd through multiple platforms. This information may help you make smarter investment decisions.
About CLGN
CollPlant Biotechnologies Ltd, formerly known as Collplant Holdings Ltd, is a company dealing in aesthetic medicine and regenerative medicine based in Israel. The company provides products and technologies for broadly understood regenerative medicine, including tissue regeneration and organ production. The technology is based on plants and is based on the production of collagen type I (rhCollagen).